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PCardiac Imaging
omparison of Radiation Doses From
ultislice Computed Tomography Coronary
ngiography and Conventional Diagnostic Angiography
uncan R. Coles, BSC, MB BS,* Mary A. Smail, MSC,† Ian S. Negus, MSC,†
eter Wilde, BSC, BM BCH,‡ Martin Oberhoff, MD,* Karl R. Karsch, MD, FACC,*
ndreas Baumbach, MD*
ristol, United Kingdom
OBJECTIVES The aim of this study was to quantify and compare effective doses from conventional
angiography and multislice computed tomography (MSCT) coronary angiography using a
16-slice scanner.
BACKGROUND Multislice computed tomography is now a viable modality for cardiac imaging. However, for
any diagnostic use of ionizing radiation, the risk to the patient must be considered and
justified.
METHODS Multislice computed tomography angiography and conventional angiography were used to
assess 180 patients with suspected coronary artery disease. Estimates of effective dose were
derived from exposure data recorded for each patient examination. For each modality, a
comparable calculation technique was used, based on Monte Carlo modeling of the standard
Cristy phantom.
RESULTS In a subset of 91 directly comparable patients the mean effective dose for MSCT coronary
angiography was 14.7 mSv (SD 2.2) and that for conventional angiography was 5.6 mSv (SD
3.6). A significant difference in effective dose was seen between the two protocols.
CONCLUSIONS The mean effective dose for MSCT coronary angiography was significantly higher than that
for conventional angiography. As MSCT cardiac scanners become increasingly available,
operators must be aware of the radiation dose and the factors that affect it. (J Am Coll
ublished by Elsevier Inc. doi:10.1016/j.jacc.2005.11.078Cardiol 2006;47:1840–5) © 2006 by the American College of Cardiology Foundation
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aoronary artery disease is a common and major cause of
remature death (1). Invasive coronary angiography is
urrently the “gold standard” investigation to detect ob-
tructive coronary artery lesions but carries a small risk of
erious complications (2). Recent developments in multi-
lice computed tomography (MSCT) technology have en-
bled the detection of coronary artery disease noninvasively
3–7), and the introduction of 16-slice scanners (8,9) has
mproved accuracy.
Radiation dose levels in diagnostic conventional coronary
ngiography (CCA) are well known (10,11). Less is known
bout radiation doses for cardiac MSCT in the clinical
etting. Coronary imaging with four-slice MSCT may give
arger radiation doses than either conventional angiography
r electron-beam computed tomography (CT) (12).
lectrocardiogram-controlled tube current modulation has
he potential to reduce patient dose in cardiac MSCT
rotocols (13,14). However, the advent of 16-slice scanners,
nd more recently 64-slice scanners, has brought increased use
From the Departments of *Cardiology, †Medical Physics and Bioengineering, and
Clinical Radiology, Bristol Heart Institute, Bristol Royal Infirmary, Bristol, United
ingdom. Dr. Coles was supported by an educational grant from Siemens, Forch-
eim, Germany. A British Heart Foundation (London, United Kingdom) grant
upported the cardiac multislice CT scanner at the Bristol Royal Infirmary.l
Manuscript received April 16, 2005; revised manuscript received August 14, 2005,
ccepted November 16, 2005.f MSCT in the diagnosis of coronary artery disease with little
ata on the accompanying radiation doses.
We compare the effective doses for a large series of
atients investigated for coronary artery disease using both
6-slice CT coronary angiography and CCA. Radiation
osimetry is complex and can only estimate dose based on
nformation about the radiographic procedure and an ana-
omic model used to represent the patient. We use the same
natomic model for both conventional and MSCT coronary
ngiography (CA), allowing a direct comparison between
hese techniques.
ETHODS
atient population. Patients presenting consecutively to
ur university hospital with suspected coronary artery dis-
ase who required in-patient CCA were recruited before-
and to undergo MSCT coronary angiography during the
ame hospital admission. Exclusion criteria were based on
echnical factors that made the patient unsuitable for
SCT coronary angiography. These were non-sinus
hythm, intolerance of beta-blockade, inability to lie flat,
nability to perform a 20-s breath hold, cardiac prostheses,
bnormal renal function (serum creatinine over 130 mmol/
), or an allergy to contrast media.
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May 2, 2006:1840–5 Radiation Dose in MSCT Coronary AngiographyThe study was fully approved by the local hospital ethics
ommittee. All patients recruited during the study period from
pril 2003 to August 2004 were included in the evaluation.
SCT coronary angiography protocol. Informed con-
ent was obtained from each patient. Patients’ heart rates
ere assessed 1 h before scanning, and if their heart rate was
bove 65 beats/min, 50 to 100 mg of oral metoprolol tartrate
Berk Pharmaceuticals, Eastbourne, United Kingdom) was
dministered.
Patients were scanned on a Sensation 16 (Siemens, Forch-
eim, Germany) with retrospective electrocardiogram-gated
econstruction. The scan sequence was a topogram, calcium-
coring scan, test bolus scan, and coronary angiogram.
The MSCT coronary angiography initially used 12 de-
ectors (software Version 60A) (group 1), then 16 detectors
nce this became available (software Version 70A) (group
). Scan parameters are listed in Table 1.
The test bolus scan was performed at the level of the
ulmonary trunk. Sequential scans were performed every 2 s
fter administration of the test bolus (20 ml Iomeron 400
Bracco, Milan, Italy] at 4 ml/s) until peak opacification in
he ascending aorta was achieved.
The angiogram covered from the pulmonary trunk to just
elow the base of the heart. Patients with known coronary
rtery bypass graft (CABG) were scanned from the sternocla-
icular joint with their arms cradled above their head. All scans
ere performed in a cranial to caudal direction. The timing of
he main injection of contrast medium (105 ml Iomeron 400 at
ml/s) was determined by the test bolus data.
SCT radiation dose. Many different dose indicators are
sed to describe medical exposures. The computed tomog-
Table 1. Multislice Computed Tomography Sc
Calciu
Pr
Group 1
Effective mAs* 133
Set kVp 120
Slice width collimation (mm) 12  1.5
Table feed per rotation (mm) 5.7
Rotation time (s) 0.42
CTDIvol (mGy) 9.6
Overscan (mm) 36
Prospective ECG gating No
Abbreviations and Acronyms
CABG  coronary artery bypass graft
CCA  conventional coronary angiography
CT  computed tomography
CTDI  computed tomography dose index
DAP  dose-area product
DLP  dose-length product
MSCT  multislice computed tomography*Effective mAs is a Siemens term that means the mA per rotation
CTDI  computed tomography dose index; ECG  electrocaraphy dose index (CTDI) represents the radiation dose
ithin a single slice under controlled conditions.
The CTDI may be measured free in air or within a
ylindrical acrylic phantom to represent dose within the
ody. The CTDIw is a weighted average of CTDI values
ithin a phantom and may be multiplied by the scan length
nd corrected for spiral pitch to give the dose-length
roduct (DLP). The CTDIw and DLP are broadly indic-
tive of patient dose and are often displayed on the scanner
onsole (15).
To maximize accuracy, we measured CTDI in air using
Radcal 2025 electrometer and 3 cm3 pencil ionization
hamber (Radcal Corp., Monrovia, California) with a
raceable calibration (Physikalisch-Technische Bunde-
anstalt [PTB], Berlin, Germany).
SCT effective dose. The calculation of effective dose in
SCT is an approximation based on a number of factors.
he CTDI is modified to take into account the best
stimate of dose absorbed by the patient; achieved using a
umber of models or conversion factors. These are designed
o reproduce the absorption characteristics of a “typical”
atient as calculated using the established phantoms of
ecognized radiation dosimetry organizations. We used the
asic conversion established by the National Radiological
rotection Board (NRPB) in the United Kingdom from
easured values of CTDI in air (16).
The NRPB used Monte Carlo modeling to estimate
rgan doses within an anthropomorphic geometrical phan-
om based on that of Cristy (17). The Imaging Performance
ssessment of CT Scanners (ImPACT) group (London,
nited Kingdom) has matched a large range of contemporary
T scanners to the most appropriate NRPB data sets. Effec-
ive doses for MSCT were estimated using the ImPACT
osimetry calculator.
CA technique. Experienced operators performed all con-
entional angiograms during routine sessions. Femoral ac-
ess was used in the majority of cases. A standard sequence
f projections was used, with variations according to need.
ost patients (84%) also had a ventriculogram. Where a
iagnostic procedure progressed to intervention, only the
arameters
oring
ls
Coronary Angiography
Protocols
Group 2 Group 1 Group 2
3 (maximum) 500 550
120 120 120
12  1.5 12  0.75 16  0.75
5.7 2.8 3.4
0.42 0.42 0.42
6 (maximum) 42.0 42.9
36 18 24
Yes No Noan P
m Sc
otoco
13
9.divided by pitch.
diogram.
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Radiation Dose in MSCT Coronary Angiography May 2, 2006:1840–5iagnostic part of the procedure was included in the
adiation dose estimate.
Three Siemens cardiac catheterization units were used: an
xiom Artis FC single-plane, an Axiom Artis BC biplane,
nd an older HiCor single-plane unit. Both Axiom units
sed automatic selection of additional copper filtration
from 0 to 0.9 mm). The HiCor unit was used with a fixed
.2-mm copper filter.
CA radiation dose. The Axiom study report for each
rocedure gave the projection, field size, kVp, additional
ltration, and dose-area product (DAP) for each acquisi-
ion, plus the DAP for each plane for fluoroscopy. Only
AP was available from the HiCor unit, so patients were
referentially assigned to the Axiom units, depending on
vailability and clinical urgency.
The DAP takes into account the intensity, duration, and
rea of the X-ray beam and is measured by an integral device
ach time an exposure is made. We checked the calibration
f each DAP meter using a Radcal 9010 electrometer and
0X5-6 ionization chamber with a traceable calibration
PTB). The DAP was corrected for attenuation by the
ouch and mattress where appropriate.
CA effective dose. A PC-based X-ray Monte Carlo
rogram (18) was used to estimate effective doses from
onventional angiography (Radiation and Nuclear Safety
gency, Helsinki, Finland). This software is more flex-
ble than the NRPB conversion factors used in previous
tudies. Like that used to estimate MSCT doses, it is
ased on the Cristy model. Although it can be adjusted to
eflect patients of other weights and heights, this was not
one, because the CT dose estimate used a standard-
ized patient.
The geometry for each projection was described by field
ize, angulation (right-left and cranial-caudal), and focus-
kin distance. The study report indicated which field was
sed for each run. Actual field dimensions were measured
sing conventional X-ray film for each nominal field size,
ssuming no further collimation. We assumed that the
ocus-image intensifier distance was 105 cm and that the
atient was 5 cm from the image intensifier face.
We assumed that the fluoroscopy geometry matched that
f the acquisitions. For cases that proceeded to intervention,
he contribution from fluoroscopy was included in propor-
able 2. Patient Characteristics
Group 1 Group 2
o. of patients 51 40
ale:female 31:20 27:13
ean age (yrs) 64 (11) 60 (10)
ean weight (kg) 78.9 (15.9) 85.1 (16.8)
ean height (cm) 168 (10) 170 (9)
ean body mass index (kg/m2) 27.8 (4.6) 29.3 (5.2)
ean heart rate (beats/min) 60 (10) 61 (7)
ata presented as mean (standard deviation).ion to the duration of the diagnostic part of the procedure.
utatistics. Differences between parameters for the two
atient groups were tested by unpaired t tests at the 95%
onfidence level (two-tailed). We assumed equal variances.
ESULTS
atient population. Of 180 patients, 176 had a cardiac
SCT (four patients withdrew before MSCT). Because 11
atients were part of an initial test phase of cardiac MSCT
rotocols and incomplete data was recorded for another 12
atients, effective doses were available for coronary MSCT
or 153 patients.
A further 62 patients had incomplete data for CCA,
ainly where the HiCor unit was used owing to clinical
rgency, and insufficient information was available to cal-
ulate effective dose accurately. Consequently 91 patients
ad effective dose measurements from both MSCT and
onventional coronary angiography for direct compari-
on. The characteristics of this population are detailed in
able 2.
ffective dose from cardiac MSCT. For the 91 directly
omparable patients the mean effective dose for MSCT
oronary angiography (including test bolus) was 14.7 mSv
SD 2.2). This increased significantly (p  0.016; two
ailed) from a mean of 14.2 mSv (SD 2.0) when using 12
etectors (group 1; n 51) to 15.3 mSv (SD 2.2) when using
ll 16 detectors (group 2; n 40). There was no significant
ifference in scan length between the two groups, indicating
hat the difference is due to increased effective mA. Results
re listed in Table 3.
The scan field was increased to image all recorded grafts
or patients with previous CABG (n  14). This increased
he mean scan length from 149 mm for non-CABG
atients to 206 mm for CABG patients. The mean effective
ose for MSCT coronary angiography was a third higher for
atients with a prior CABG: 19.4 mSv compared with 14.3
Sv for non-CABG patients.
ffective dose from CCA. For the directly comparable
atients the mean DAP for CCA was 27.6 Gy·cm2, and the
ean effective dose was 5.6 mSv. There was no significant
ifference in DAP or fluoroscopy time between the directly
omparable patients and those excluded due to incomplete
ata. Dose data are shown in Table 4. Figure 1 compares
able 3. Effective Dose from Multislice Computed Tomography
oronary Angiography
Group 1
(12 Detectors)
Group 2
(16 Detectors) p Value
ean effective dose from test
bolus scans (mSv)
0.70 (0.21) 0.84 (0.38) 0.022
ean scan length (mm) 151 (20) 156 (20) 0.217
ean DLP (mGy·cm) 642 (83) 685 (85) 0.019
ean effective dose (mSv) 13.5 (2.0) 14.5 (2.2) 0.033
ean effective dose including
test bolus (mSv)
14.2 (2.0) 15.3 (2.2) 0.016
ata presented as mean (standard deviation) with p values from a two-tailed t test
sed to test for a significant difference.
DLP  dose-length product.
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May 2, 2006:1840–5 Radiation Dose in MSCT Coronary Angiographyhe effective doses for coronary angiograms using both
echniques.
The mean effective dose for CABG patients (n  7) was
.3 mSv and that for non-CABG patients was 5.8 mSv. The
ABG sample size was too small to make a meaningful
omparison.
ISCUSSION
ur study demonstrates that MSCT coronary angiography
n a 16-slice scanner gives a significantly higher effective
ose than CCA when evaluating patients with suspected
oronary artery disease.
Values such as CTDI and DAP do not allow comparison
etween different imaging modalities. Effective dose takes
nto account the amount of radiation absorbed in different
rgans and tissues, the relative biologic effectiveness of the
adiation used, and the differing radiosensitivities of each
rgan and tissue. It can therefore be used to compare
ifferent imaging modalities. We directly compared the
ffective dose for coronary angiography using two different
echniques, which had not been performed in a patient
opulation before.
Table 4. Effective Dose from Conventional Co
Group 1
Mean no. of acquisitions 12.8 (2.3)
Mean fluoroscopy time (min) 4.5 (3.0)
Mean DAP (Gy·cm2) 27.9 (15.1)
Mean effective dose (mSv) 5.8 (3.7)
Data presented as mean (standard deviation) with p values f
DAP  dose-area product.Figure 1. Effective doses from multislice computed tomograIn comparing dose estimates, differences in scanner type
nd scan protocol are key factors to consider. Initial dose
stimates for MSCT coronary angiography using four-slice
canners were lower than our data. Those estimates used
hantom measurements (12) and a DLP method (19) on a
mall series of patients, unlike our larger patient cohort in a
eal clinical setting. We found a higher effective dose than
tudies (14,20) assessing 16-slice CT angiography, because
ur average clinical scan length was longer than the scan
engths used in those phantom studies.
When we moved from 12 to 16 detectors, the radiation
ose increased in proportion to the manufacturer’s recom-
ended effective mAs. This does not predict what will
appen for greater numbers of detectors, because various
actors influence radiation exposure, including the geomet-
ic efficiency of the beam and the resultant overscan. Bolus
racking may reduce radiation exposure, but as the test bolus
can contributed 5% to overall dose, this reduction is likely
o be small.
Clearly our results refer to the protocols in place at the
ime of the study. Fixed exposure settings were used for all
atients. Ideally, operators should optimize protocols to
chieve adequate image quality for different-sized patients
ry Angiography
Group 2 All Patients p Value
12.2 (3.7) 12.5 (3.0) 0.330
4.0 (2.3) 4.3 (2.7) 0.732
27.3 (16.1) 27.6 (15.5) 0.842
5.4 (3.4) 5.6 (3.6) 0.674
two-tailed t test used to test for a significant difference.ronaphy (MSCT) and conventional coronary angiography.
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Radiation Dose in MSCT Coronary Angiography May 2, 2006:1840–5nd should be aware of the impact this will have on patient
ose.
Patients also had a calcium-scoring scan using 12 detec-
ors, which covered from the carina to just below the base of
he heart (mean scan length 182 mm). For the directly
omparable patients, the mean effective dose was 4.1 mSv
or group 1, but only 2.6 mSv for group 2 when
lectrocardiogram-controlled tube current modulation was
sed. The effective dose from the topogram is small,
ypically in the range of 0.1 to 0.2 mSv.
Our population, studied in a modern cardiac catheteriza-
ion laboratory, gave similar DAP values to those in the
iterature for diagnostic angiography (21). Our estimates of
ffective doses were also similar to those from other studies.
owever, our use of the Monte Carlo program allowed us
o better model the geometries and beam characteristics
sed for individual patients.
The International Commission on Radiological Protec-
ion has estimated the additional lifetime risk of fatal cancer
s approximately 1 in 20,000 per mSv for the whole
opulation (22). Although this risk is lower for the geriatric
opulation generally investigated for coronary artery disease,
ignificant reductions in risk will only be seen in patients in
heir 70s and 80s. Our subjects had an average age of 63
ears.
A coronary CT angiogram with an effective dose of 14.7
Sv has a risk of inducing a fatal cancer of 1 in 1,400.
onventional coronary angiography (5.6 mSv) has a risk of
in 3,600, and a calcium-scoring scan (2.6 mSv) a risk of 1
n 7,700. To put this in context, a typical effective dose for
rest-stress myocardial single photon emission CT scan
sing technetium-99m is 8 mSv and that for a myocardial
can using thallium-201 is 18 mSv (23).
Coronary CT gives a higher risk of cancer than conven-
ional angiography, although it is without the invasive
ortality and morbidity risks. Radiation-induced skin inju-
ies have been reported for interventional procedures carried
ut under fluoroscopic guidance (24,25); the risk of skin
njury is greater when long or multiple procedures are
arried out. Diagnostic procedures are unlikely to result in
kin injury, and a comparison of skin doses from conven-
ional angiography and MSCT is beyond the scope of this
aper. Risks from contrast administration are inherent to
oth imaging techniques.
tudy limitations. The anatomic model used to calculate
ffective dose will influence accuracy. Patient-specific do-
imetry is not generally available for MSCT. Therefore,
alculations do not allow for individual variation in weight,
eight, or gender but are based on a “standard” hermaph-
odite adult with a weight of 71 kg and height of 174 cm.
ur population was shorter and heavier than this model,
eflecting the overweight population investigated for coro-
ary artery disease. Fluoroscopy systems automatically ad-
ust the amount of radiation delivered for body size, whereas
urrent cardiac CT protocols do not offer this facility.
1onclusions. Coronary CT delivers a relatively high radi-
tion dose for a purely diagnostic procedure. It also delivers
significantly higher effective dose than conventional an-
iography to patients being investigated for coronary artery
isease. With the increasing availability of MSCT cardiac
canners, operators must be aware of the radiation dose, and
he factors that affect it, for both clinical and research
rotocols.
As the clinical role of noninvasive CT coronary angiog-
aphy develops, clinicians should remember that the use of
onizing radiation in medical exposures should be both
ustified and optimized. Further work is needed to deter-
ine optimal scan protocols. Future studies, using the next
eneration of CT scanners with 64 or more detectors, must
rovide information on their radiation exposure when eval-
ating the clinical use of cardiac CT.
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